• Main
  • Molecular Mechanisms of Drugs for Neuropsychiatric Disorders

    Prof. Moshe Rehavi, Ph.D.
    Department of Physiology and Pharmacology

    Main projects in the lab include:

    1. Presynaptic monoamine transportes and the vesicular monoamine transporter as targets for neuropsychiatric drugs.
    2. Anxiolytic effects of new herbal treatment: mice models of anxiety and biochemical studies.
    3. Quaternary serotonin-reuptake inhibitors as novel anti-platelet drugs.
    4. Methylphenidate (Ritalin): abuse potential and long-term effects.
    5. Neuronal rescue by Rasagiline (MAO-B inhibitor) in thiamine deficiency.

     

    Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
    UI/UX Basch_Interactive